Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

59.11
+0.94001.62%
Post-market: 58.81-0.3000-0.51%17:40 EDT
Volume:343.75K
Turnover:20.37M
Market Cap:2.26B
PE:-9.83
High:61.25
Open:60.27
Low:58.81
Close:58.17
52wk High:99.50
52wk Low:30.82
Shares:38.16M
Float Shares:32.89M
Volume Ratio:0.44
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0116
EPS(LYR):-6.0116
ROE:-35.86%
ROA:-22.55%
PB:3.05
PE(LYR):-9.83

Loading ...

Assessing Disc Medicine (IRON) Valuation After FDA Review Delay And Heightened Regulatory Focus

Simply Wall St.
·
Jan 18

Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action

Benzinga
·
Jan 17

Disc Medicine: Bitopertin’s Accelerated Approval Path and FDA Timing Support Buy Rating and $118 Target

TIPRANKS
·
Jan 16

EXCLUSIVE-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns

Reuters
·
Jan 16

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires Live
·
Jan 16

Reported timing of Disc Medicine review date a positive, says Morgan Stanley

TIPRANKS
·
Jan 16

Disc Medicine falls -6.8%

TIPRANKS
·
Jan 16

Analysts Offer Insights on Healthcare Companies: Penumbra (PEN) and Disc Medicine (IRON)

TIPRANKS
·
Jan 16

FDA pushes back reviews of several fast-tracked medicines, Reuters reports

TIPRANKS
·
Jan 15

Disc Medicine selloff brings buying opportunity, says Wedbush

TIPRANKS
·
Jan 15

FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks

Benzinga_recent_news
·
Jan 15

Market Chatter: Sanofi, Disc Medicine Drug Reviews Delayed as FDA Flags Safety, Efficacy Issues

MT Newswires Live
·
Jan 15

Exclusive-FDA Pushes Back Review of Sanofi's Diabetes Drug Tzield and Disc Medicine's Blood Disorder Drug -Documents

THOMSON REUTERS
·
Jan 15

Disc Medicine Inc. i Unveils Hematology Pipeline and Bitopertin Launch Strategy in New Corporate Presentation

Reuters
·
Jan 15

How Disc Medicine’s New HR Chief and Bitopertin Review Could Shape IRON’s Commercial Readiness

Simply Wall St.
·
Jan 14

Disc Medicine Says FDA Engagement Over Bitopertin Remains Productive -- Market Talk

Dow Jones
·
Jan 14

Wedbush Sticks to Their Buy Rating for Disc Medicine (IRON)

TIPRANKS
·
Jan 13

Analysts Have Conflicting Sentiments on These Healthcare Companies: Disc Medicine (IRON), Nuvalent (NUVL) and Roche Holding AG (OtherRHHVF)

TIPRANKS
·
Jan 13

Disc Medicine Appoints Lisa Amaya Price as Chief Human Resources Officer

Reuters
·
Jan 13

Disc Medicine highlights recent pipeline progress, priorities for 2026

TIPRANKS
·
Jan 12